EcoDrugPlus

G Protein-Coupled Receptor 84

Ensembl ID : ENSFHEG00000013379
Gene Symbol: GPR84
3 Cross references
114 Possible Orthologues:

Hck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSFHEG00000014226
Gene Symbol: HCK
3 Cross references
203 Possible Orthologues:

Il2 Inducible T Cell Kinase

Ensembl ID : ENSFHEG00000022190
Gene Symbol: ITK
3 Cross references
208 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSFHEG00000001301
Gene Symbol: JAK1
3 Cross references
214 Possible Orthologues:

Kras Proto-Oncogene, Gtpase

Ensembl ID : ENSFHEG00000009108
Gene Symbol: KRAS
3 Cross references
208 Possible Orthologues:

Malt1 Paracaspase

Ensembl ID : ENSFHEG00000004071
Gene Symbol: MALT1
2 Cross references
198 Possible Orthologues:

Map Kinase-Interacting Serine/threonine-Protein Kinase 2

Ensembl ID : ENSFHEG00000021979
Gene Symbol: LOC105939311
3 Cross references
208 Possible Orthologues:

Mapk Activated Protein Kinase 2

Ensembl ID : ENSFHEG00000021600
Gene Symbol: MAPKAPK2
3 Cross references
186 Possible Orthologues:

Mcl1, Bcl2 Family Apoptosis Regulator

Ensembl ID : ENSFHEG00000009084
Gene Symbol: LOC105936529
3 Cross references
211 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSFHEG00000010597
Gene Symbol: MDM2
3 Cross references
282 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSFHEG00000010079
Gene Symbol: MET
3 Cross references
204 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog

Ensembl ID : ENSFHEG00000015660
Gene Symbol: MLST8
3 Cross references
198 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).